Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Firibastat (QGC001) | 648927-86-0 | 98.0% | 368.51 | 1 MG
SDP

Catalog No. 5000344747
Encompass_Preferred

Firibastat (QGC001), an orally active brain penetrating proagent of EC33, is a first-in-class brain aminopeptidase A (APA) inhibitor with a Ki of 200 nM. It selectively and specifically inhibits the conversion of brain angiotensin-II into angiotensin-III and decreases blood pressure in hypertensive rats.

  • Orally active and brain penetrating.
  • Functions as a proagent.
  • First-in-class brain aminopeptidase A (APA) inhibitor.
  • Selectively inhibits conversion of brain angiotensin-II into angiotensin-III.
  • Decreases blood pressure in hypertensive rats.
  • Crosses gastrointestinal and blood-brain barriers.
  • Generates two active molecules that inhibit brain APA activity.
  • Blocks brain angiotensin III formation.

Catalog No. 50-003-44747 Supplier Medchemexpress LLC Supplier No. HY10905810MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Firibastat (QGC001), an orally active brain penetrating proagent of EC33, is a first-in-class brain aminopeptidase A (APA) inhibitor with a Ki of 200 nM. It selectively and specifically inhibits the conversion of brain angiotensin-II into angiotensin-III and decreases blood pressure in hypertensive rats.

  • Orally active and brain penetrating.
  • Functions as a proagent.
  • First-in-class brain aminopeptidase A (APA) inhibitor.
  • Selectively inhibits conversion of brain angiotensin-II into angiotensin-III.
  • Decreases blood pressure in hypertensive rats.
  • Crosses gastrointestinal and blood-brain barriers.
  • Generates two active molecules that inhibit brain APA activity.
  • Blocks brain angiotensin III formation.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.